Literature DB >> 21463902

Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.

Stephen Z Levine1, Jonathan Rabinowitz, Dimitris Rizopoulos.   

Abstract

The adequacy of the Positive and Negative Syndrome Scale (PANSS) items in measuring symptom severity in schizophrenia was examined using Item Response Theory (IRT). Baseline PANSS assessments were analyzed from two multi-center clinical trials of antipsychotic medication in chronic schizophrenia (n=1872). Generally, the results showed that the PANSS (a) item ratings discriminated symptom severity best for the negative symptoms; (b) has an excess of "Severe" and "Extremely severe" rating options; and (c) assessments are more reliable at medium than very low or high levels of symptom severity. Analysis also showed that the detection of statistically and non-statistically significant differences in treatment were highly similar for the original and IRT-modified PANSS. In clinical trials of chronic schizophrenia, the PANSS appears to require the following modifications: fewer rating options, adjustment of 'Lack of judgment and insight', and improved severe symptom assessment. 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21463902     DOI: 10.1016/j.psychres.2011.03.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.

Authors:  Søren D Østergaard; Leslie Foldager; Ole Mors; Per Bech; Christoph U Correll
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

Review 2.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

3.  Insight, positive and negative symptoms, hope, depression and self-stigma: a comprehensive model of mutual influences in schizophrenia spectrum disorders.

Authors:  B Schrank; M Amering; A Grant Hay; M Weber; I Sibitz
Journal:  Epidemiol Psychiatr Sci       Date:  2013-07-24       Impact factor: 6.892

Review 4.  Rating scales measuring the severity of psychotic depression.

Authors:  S D Østergaard; A J Rothschild; A J Flint; B H Mulsant; E M Whyte; A K Leadholm; P Bech; B S Meyers
Journal:  Acta Psychiatr Scand       Date:  2015-05-27       Impact factor: 6.392

5.  Brief Clinical Assessment Scale for Schizophrenia (BCASS): Development, Validity, and Reliability Study.

Authors:  Mustafa Yildiz; Aysel Incedere; Mehmet Buğrahan Gürcan; Emre Osman
Journal:  Noro Psikiyatr Ars       Date:  2021-08-04       Impact factor: 1.339

6.  Disparity between General Symptom Relief and Remission Criteria in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor Item Response Theory Model.

Authors:  Ariana E Anderson; Steven P Reise; Stephen R Marder; Maxwell Mansolf; Carol Han; Robert M Bilder
Journal:  Innov Clin Neurosci       Date:  2017-12-01

7.  Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Anzalee Khan; Charles Lewis; Jean-Pierre Lindenmayer
Journal:  BMC Psychiatry       Date:  2011-11-16       Impact factor: 3.630

8.  A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups.

Authors:  Anzalee Khan; Christian Yavorsky; Stacy Liechti; Mark Opler; Brian Rothman; Guillermo DiClemente; Luka Lucic; Sofija Jovic; Toshiya Inada; Lawrence Yang
Journal:  BMC Psychol       Date:  2013-03-11

9.  The effects of systematic psychological nursing on the sleep quality of schizophrenic patients with sleep disorders.

Authors:  Manru Li; Bibo Lang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  Visual Hallucinations in First-Episode Psychosis: Association with Childhood Trauma.

Authors:  Martine Solesvik; Inge Joa; Tor Ketil Larsen; Johannes Langeveld; Jan Olav Johannessen; Jone Bjørnestad; Liss Gøril Anda; Jens Gisselgård; Wenche Ten Velden Hegelstad; Kolbjørn Brønnick
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.